Received: 25 September 2019
Accepted: 2 April 2020
First Online: 9 April 2020
Ethics approval and consent to participate
: The use of the ADSC system device does not need approval by any ethical committee as it is a homologous transplant. In addition, the treatment was carried out before the publication of RD 1090/2015 of December 4, by which the Ethics Committees of Drug Research are regulated in Spain. Of course, patients were informed both verbally and in writing by informed consent.
: Not applicable
: All authors work directly or indirectly for Lyposmol Biotech, a biotechnology company whose objectives include research, development, and commercialization of Regenerative Medicine and Cell Therapy products.